医学
内科学
曲妥珠单抗
肿瘤科
转移性乳腺癌
乳腺癌
临床试验
荟萃分析
不利影响
人口
恶心
入射（几何）
癌症
物理
环境卫生
光学
作者
Zaheer Qureshi,Faryal Altaf,Abdur Jamil,Rimsha Siddique,Eeshal Fatima
标识
DOI：10.1097/coc.0000000000001126
摘要
Trastuzumab deruxtecan (T-DXd) is a novel antibody-drug conjugate (ADC) promising in treating metastatic HER2+ and HER2-low breast cancer. This updated systematic review and meta-analysis, integrating data from the latest clinical trials, aimed to evaluate the safety and efficacy of T-DXd in this patient population.
科研通智能强力驱动
Strongly Powered by AbleSci AI
SYLH
许甜甜鸭
冰魂
sunyz
cdercder
个性归尘
jenningseastera
一一
nozero
丰知然
从容芮
pluto
昏睡的蟠桃
iNk
OCDer
乐乐乐乐乐乐
HEIKU
难过板栗
懵懂的采梦
若雨凌风
皖公网安备34019202002308
